Evidence map›Paper›PMID 30621697›Full record

ArticleBMC health services research2019

Implementation of an interprofessional medication adherence program for chronic patients in community pharmacies: how much does it cost for the provider?

Clemence Perraudin, Jean-François Locca, Christophe Rossier, Olivier Bugnon, Marie-Paule Schneider

Abstract read
In one paragraph

Article in BMC health services research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Clemence PerraudinDepartment of Ambulatory Care and Community Medicine, Community Pharmacy Center, University of Lausanne, Lausanne, Switzerland. Clemence.perraudin@hospvd.ch.ORCID http://orcid.org/0000-0002-3533-2764
Jean-François LoccaPharmacie de Prilly, Community Pharmacy, Prilly, Switzerland.
Christophe RossierPharmacie de l'Ile, Community Pharmacy, Rolle, Switzerland.
Olivier BugnonDepartment of Ambulatory Care and Community Medicine, Community Pharmacy Center, University of Lausanne, Lausanne, Switzerland.
Marie-Paule SchneiderDepartment of Ambulatory Care and Community Medicine, Community Pharmacy Center, University of Lausanne, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe implementation of an innovative and sustainable professional pharmacy service in routine care requires substantial resources borne by the pharmacy owner. Although a community pharmacy is a business setting, few studies have examined cost as a potential barrier to widespread implementation. Implementation costs, as the cost impact of an implementation effort, can be significant and hamper the decision to invest from the provider perspective. Traditional financial planning tools can be used to analyse and support business decision to implement a service by assessing the net impact of a new service on the provider's budget. This study aimed to estimate the implementation costs and the break-even point of an interprofessional medication adherence program for chronic patients in Switzerland. The program combines motivational interviews, medication adherence electronic monitoring and feedback reports to patient and physicians.

methodsWe used a 3-step approach: (i) micro-costing analysis: identification of implementation activities, quantification and valuation of required resources. Implementation costs, including service support costs and direct delivery costs, were analysed according to the implementation phase (installation, initial implementation, and full operation); (ii) break-even analysis: estimation of the required number of patients to follow up with to ensure that the generated revenue exceeded the total cost; and (iii) univariate sensitivity analyses.

resultsThe estimated total cost of the installation phase was 8481 CHF, more than half of which represented the cost of the equipment. Direct delivery costs were 666 CHF per patient per year, with 68% of this value associated with the cost of workforce time. According to the Swiss national reimbursement system, a minimal of 16 [10-27] patients was required to cover the implementation costs of the installation phase. This break-even point decreased to 13 patients in the initial and full operation phases.

conclusionsThese estimates lead to a better understanding of the real cost of implementing a professional pharmacy service in routine care. In a Swiss context, the current medication adherence support fee-for-service system allows pharmacists to reach the break-even point. Such information is important for community pharmacists to guide their implementation strategies. The replication of similar analyses in other settings and countries is paramount.

Indexed as

Drug MonitoringChronic DiseaseCommunity Pharmacy ServicesHealth Care CostsHealth ResourcesHealth Services ResearchHumansInterprofessional RelationsMedication Therapy ManagementPharmacistsPhysiciansProgram DevelopmentSwitzerlandBreak-even analysisCommunity pharmacyCost analysisIMAPImplementationMedication adherence

Identifiers

PMID30621697
PMCPMC6323833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.